Why the study?
Does HDT as consolidation therapy improve overall survival in patients with relapsed Ewing's Sarcoma Family of Tumors?
Does HDT as consolidation therapy improve overall survival in patients with relapsed Ewing's Sarcoma Family of Tumors?
High-dose therapy as consolidation may improve overall survival in patients with relapsed Ewing's Sarcoma Family of Tumors.
Hypothesis-generating for HDT in relapsed ESFT; randomized trials needed before practice change.
HDT as consolidation therapy for relapsed ESFT seems to be associated with improved OS, even after adjusting for RFI and response to second-line treatment.
No takes yet. Share an insight, caveat, or question.
Barker et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: